Literature DB >> 11357471

Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.

L Hounsom1, R Corder, J Patel, D R Tomlinson.   

Abstract

AIMS/HYPOTHESIS: This study compared the effects of streptozotocin-induced diabetes in rats with those of two pro-oxidant interventions; a diet deficient in vitamin E and treatment with primaquine.
METHODS: Measurements were made by the classic motor and sensory conduction velocity deficits and by indicators of the breakdown of small fibre phenotype i.e., sciatic nerve content of nerve growth factor and the neuropeptides, substance P and neuropeptide Y.
RESULTS: As with diabetes, the pro-oxidant interventions decreased conduction velocities (though the effect of vitamin E deficiency was not significant), the sciatic nerve content of nerve growth factor and the neuropeptides (all percentages refer to the mean value for the appropriate control groups). In diabetes, nerve growth factor was depleted to 50% in the control rats (p < 0.05); oxidative stress depleted nerve growth factor to 64% (primaquine; p < 0.05) and 81% (vitamin E deficient; not significant) of controls. Substance P was depleted to 51% in the control rats (p < 0.01) with depletions to 74% and 72% (both p < 0.01) by oxidative stress; equivalent depletions for neuropeptide Y were 38% controls in diabetes (p < 0.001) and 67% (primaquine; p < 0.001) and 74% (vitamin E deficient; p < 0.05) for oxidative stress. CONCLUSION/
INTERPRETATION: The relative magnitudes of these changes suggest an effect in diabetes of oxidative stress, coupled with some other cellular event(s). This is supported by the effects of a diester of gamma-linolenic acid and alpha-lipoic acid, which completely prevented the effects on the pro-oxidant interventions on conduction velocity, nerve growth factor and neuropeptide contents, but was only partially preventative in diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357471     DOI: 10.1007/s001250051638

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

Review 1.  Oxidative stress and diabetic neuropathy: a new understanding of an old problem.

Authors:  Eva L Feldman
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Hiroko Hirooka; Jerry L Nadler; Irina G Obrosova
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

3.  Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

Authors:  Irina G Obrosova; Viktor R Drel; Pal Pacher; Olga Ilnytska; Zhong Q Wang; Martin J Stevens; Mark A Yorek
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Vincristine-induced neuropathy in rat: electrophysiological and histological study.

Authors:  Feras M H Ja'afer; Farqad B Hamdan; Faiq H Mohammed
Journal:  Exp Brain Res       Date:  2006-05-31       Impact factor: 1.972

5.  Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Authors:  Olga Ilnytska; Valeriy V Lyzogubov; Martin J Stevens; Viktor R Drel; Nazar Mashtalir; Pal Pacher; Mark A Yorek; Irina G Obrosova
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

6.  Age-dependent slowing of enteric axonal transport in insulin-resistant mice.

Authors:  Kathy J LePard; Joseph Cellini
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy.

Authors:  Nigel A Calcutt; Karen L Allendoerfer; Andrew P Mizisin; Alicia Middlemas; Jason D Freshwater; Monica Burgers; Rigel Ranciato; Jean-Dominique Delcroix; Frederick R Taylor; Renee Shapiro; Kathy Strauch; Henryk Dudek; Thomas M Engber; Alphonse Galdes; Lee L Rubin; David R Tomlinson
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 8.  Future treatments for diabetic neuropathy: clues from experimental neuropathy.

Authors:  Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 9.  Hyperglycemia-induced oxidative stress in diabetic complications.

Authors:  George L King; Mary R Loeken
Journal:  Histochem Cell Biol       Date:  2004-07-15       Impact factor: 4.304

10.  SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James W Russell; Kelli A Sullivan; Carey Backus; John M Hayes; Lisa L McLean; Eva L Feldman
Journal:  Exp Neurol       Date:  2007-08-03       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.